mHealth, or mobile health technology used in medical care, is unlocking unprecedented solutions for the healthcare sector, saving lives, and relieving healthcare systems. Wearables — including health-monitoring devices, implantables, and digestibles — are a key technology, and are becoming increasingly relevant to various life sciences sectors, such as pharma and biotech, as companies seek to better understand, prevent, detect, and manage disease. Companies operating in MedTech and wearable technology turn to Sidley for guidance in navigating this rapidly growing space. Our lawyers bring an interdisciplinary approach to problem-solving, coupled with strong knowledge of regulatory frameworks and backgrounds in science, technology, and data privacy, including in the context of the Internet of Things, Big Data, artificial intelligence/machine learning (AI/ML), and cloud solutions. Drawing upon the firm’s market-leading resources — spanning transactional, litigation, and regulatory experience — we work alongside companies to provide business-oriented advice throughout the entire life cycle of a digital health product or service. Our lawyers have a nuanced understanding of the multifaceted issues confronting companies not only in their day-to-day operations, but also as new challenges arise.
“Law Firm of the Year” in FDA Law
2022 U.S. News – Best Lawyers® “Best Law Firms” Survey
How We Add Value
Digital health technology companies around the world seek our advice in supporting their efforts to develop mobile apps, platform technologies, wearables, and other health IT to promote wellness and improve healthcare. In addition, our lawyers assist companies in the pharmaceutical, food, cosmetics, and novel products sectors with their entry into the digital health space.
Our global platform and multidisciplinary practice offerings allow us to seamlessly counsel multinational mHealth companies as they contend with varying regulatory regimes across the U.S., Europe, and Asia. Our clients include healthcare providers, software and technology providers/manufacturers, insurance providers, publishers, and pharmaceutical companies operating across the traditional life sciences industry and beyond, ranging from startups to established investors and global companies. We advise these leading companies on all aspects of their businesses, from proof-of-concept and pre-marketing development and authorization, to post-marketing and pre-litigation risk assessments.